Update on Ozempic availability – February 2023

Teplizumab (Tzield): A new drug to delay the onset of type 1 diabetes is approved in the US

Heart disease: A serious complication of diabetes

Artificial pancreas effective in type 2 diabetes: trial

Leading public health organisations back AMA’s call for sugary drinks levy

Diabetes eLearning health program wins Gold award